An2 Therapeutics
(NASDAQ) ANTX
An2 Therapeutics Financials at a Glance
Market Cap
$129.78M
Revenue (TTM)
$0.00
Net Income (TTM)
$35.17M
EPS (TTM)
$-1.16
P/E Ratio
-3.10
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$3.62
Volume
4,062
Open
$3.23
Price
$3.62
Volume
4,062
Open
$3.23
Previous Close
$3.62
Daily Range
$3.13 - $3.62
52-Week Range
$1.00 - $6.91
Dividend
$0.00
Beta (Volatility)
0.83 (Low)
Price
$3.62
Volume
4,062
Open
$3.23
Previous Close
$3.62
Daily Range
$3.13 - $3.62
52-Week Range
$1.00 - $6.91
ANTX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout An2 Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
21
CEO
Eric Easom, MBA
Website
www.an2therapeutics.comHeadquarters
Menlo Park, CA 94027, US
ANTX Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-52%
Return on Capital
-72%
Return on Assets
-57%
Earnings Yield
-32.26%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$129.78M
Shares Outstanding
35.95M
Volume
4.06K
Short Interest
0.00%
Avg. Volume
1.41M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$38.11M
EBITDA
$38.11M
Operating Cash Flow
$29.83M
Capital Expenditure
$0.00
Free Cash Flow
$29.83M
Cash & ST Invst.
$58.00M
Total Debt
$0.00
An2 Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$129.78M
N/A
Market Cap/Employee
$5.90M
N/A
Employees
22
N/A
Net Income
$8.71M
-15.8%
EBITDA
$10.00M
N/A
Quarterly Fundamentals
Net Cash
$58.00M
-30.6%
Accounts Receivable
$900.00K
+200.0%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$0.00
N/A
Return on Assets
-56.78%
N/A
Return on Invested Capital
-71.59%
N/A
Free Cash Flow
$5.24M
+0.7%
Operating Cash Flow
$5.24M
+0.7%